Publications & Works

Publication Network
Articles 12
All (12)
SCI-E, SSCI, AHCI (8)
SCI-E, SSCI, AHCI, ESCI (9)
ESCI (1)
Scopus (9)
TRDizin (3)
Other Publications (2)

1. The impact of cART on hepatic steatosis and fibrosis in treatment-naïve PLwHIV: A prospective cohort study

Sahin Ozdemir M., Ozdemir Y. E., Dogdas A., NURIYEV K., ŞENKAL İ. V., Gunduz A., et al.
International Journal of STD and AIDS , vol.37, no.2, pp.158-168, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

2. A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease

İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., İmanov Z., et al.
Scientific Reports , vol.15, no.1, 2025 (SCI-Expanded) identifier identifier identifier

3. Real World Efficacy and Safety of Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Liver Transplant Recipients

Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.
Transplant Infectious Disease , vol.27, no.5, 2025 (SCI-Expanded, Scopus) Sustainable Development identifier

4. USTEKINUMAB EFFECTIVENESS AND SUSTAINABILITY IN ULCERATIVE COLITIS AND CROHN’S DISEASE

İstemihan Z., Teberik Kama E., Altın S., İmanov Z., Şenkal İ. V., Nurıyev K., et al.
Journal of İstanbul Faculty of Medicine , no.88, pp.256-263, 2025 (Peer-Reviewed Journal)

5. Anxiety and Depression Outcomes in Liver Transplant Candidates and Recipients Using the Hospital Anxiety and Depression Scale

Bardak A. E., Cifcibasi Ormeci A., Yildiz Z., Senkal V., Imanov Z., Istemihan Z., et al.
Transplantation Proceedings , vol.57, no.6, pp.1170-1175, 2025 (SCI-Expanded) Sustainable Development identifier identifier

6. The role of GALAD score in the surveillance of hepatocellular carcinoma.

İstemihan Z., Şenkal İ. V., Karaca D., Nurıyev K., Rustamzade A., Genç Uluçeçen S., et al.
Scientific reports , vol.15, no.1, pp.22279, 2025 (SCI-Expanded, Scopus) identifier identifier

7. Virological and Biochemical Effects of Tenofovir Alafenamide in Different Patient Groups With Chronic Hepatitis B Virus Infection in Real-World Cohort

Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.
International Journal of Hepatology , vol.2025, no.1, 2025 (ESCI, Scopus) identifier

8. What are the predictors of malignancy in inflammatory bowel disease?

İstemihan Z., Çavuş B., Bardak A. E., Kirkoğlu A. M., Kiziltaş C., Silay R., et al.
Turkish Journal of Medical Sciences , vol.55, no.4, pp.846-854, 2025 (SCI-Expanded) identifier identifier identifier

9. Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH)

Büyük M., Berker N., Vurallı Bakkaloğlu D., Şenkal İ. V., Önal Z., Güllüoğlu M.
HEPATOLOGY INTERNATIONAL , vol.18, no.3, pp.1011-1019, 2024 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

10. Different Faces of Eosinophilic Infiltration of Gastrointestinal System

İSTEMİHAN Z., ÇAVUŞ B., BERKER N., Nuriyev K., Şenkal V., İmanov Z., et al.
Journal of Enterocolitis , vol.1, no.3, pp.68-71, 2022 (TRDizin)

11. Are Hepatobiliary Manifestations Related to the Site of Involvement in Inflammatory Bowel Disease?

İstemihan Z., Çifcibaşı Örmeci A., Çavuş B., Şenkal İ. V., İmanov Z., Nuriyev K., et al.
Journal of Enterocolitis , vol.1, pp.12-16, 2022 (Peer-Reviewed Journal)

12. Is Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2?

Çavuş B., Akyüz F., Örmeci Çifçibaşı A., Özgür İ., Erel C., Yakut A., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, no.3, pp.196-204, 2022 (SCI-Expanded, Scopus, TRDizin) Sustainable Development identifier identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 14

1. HYPERLIPIDEMIA, ATHEROSCLEROSIS AND HEPATOSTEATOSIS IN PRIMARY BILIARY CHOLANGITIS: WHAT IS THE RISK?

ÇOŞKUN A., Ormeci A. C., ÇAVUŞ B., ŞENKAL İ. V., KARAPINAR E., POYANLI A., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 10 - 14 November 2023, (Summary Text) identifier

2. ARE THERE NEW PRACTICAL MARKERS TO PREDICT MALIGNANCY IN PANCREATIC CYST FLUIDS?

Anıl K. U., Çavuş B., Çifcibaşı Örmeci A., İmanov Z., Şenkal İ. V., Nurıyev K., et al.
Digestive Disease Week 2023, Washington, United States Of America, 6 - 09 May 2023, pp.774, (Summary Text)

3. Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects

Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.
39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 22 - 27 November 2022, pp.1159-1162, (Summary Text)

4. İDYOPATİK NONSİROTİK PORTAL HİPERTANSİYON TANILI KARACİĞER BİYOPSİLERİNDE HİSTOMORFOLOJİK VE İMMÜNHİSTOKİMYASAL (CD34, GLUTAMİN SENTETAZ) BULGULARIN ANALİZİ

Büyük M., Berker N., Şenkal İ. V., Önal Z., Güllüoğlu M.
31. Ulusal Patoloji Kongresi, İzmir, Turkey, 26 - 30 October 2022, vol.6, pp.65-70, (Summary Text)

5. A RARE CAUSE OF HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: VISCERAL LEISHMANIASIS

Yılmaz A., Bektaş E., Bilgin E., Şenkal İ. V., Çavuş B., Çifcibaşı Örmeci A., et al.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.118-119, (Full Text) Sustainable Development

6. REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS

Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.
AASLD Liver Meeting , District Of Columbia, United States Of America, 4 - 08 November 2022, vol.76, pp.299, (Summary Text)

7. İshal ve kilo kaybının nadir bir nedeni:Amiloidoz

Çiftçi A. C., Konyaoğlu H., Şenkal İ. V., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., et al.
21. Çapa Gastroenteroloji Günleri, İstanbul, Turkey, 31 March - 02 April 2022, pp.70, (Full Text)

8. A CASE OF HEMOCHROMATOSIS PRESENTING WITH BILATERAL AVASCULAR NECROSIS OF THE FEMORAL HEAD

Yılmaz A., Bektaş E., Gülseren Ü. A., Şenkal İ. V., Nurıyev K., Altınkaynak M., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2022, Sakarya, Turkey, 23 - 27 March 2022, pp.38-39, (Full Text)

9. Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi

İstemihan Z., Nurıyev K., Şenkal İ. V., İmanov Z., Sarıdal M. K., Akas R., et al.
38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.219, (Summary Text) Sustainable Development

10. Girişimsel Gastroenterolojik İşlemlerde Hastaların Doktor Tercihinde Cinsiyet Önemli mi?

Kara İnci A., Zaralı S., Akyüz M., İmanov Z., Şenkal İ. V., İstemihan Z., et al.
38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.204, (Full Text)

11. Renal transplant alıcılarında AA amiloidoz nüksünü saptamada non-invazif bir yöntem olarak transient elastografi (fibroscan)

Bektaş M., Dirim A. B., Çavuş B., Sarı S., Şenkal İ. V., Ağargün B. F., et al.
Romatolojide Hedef 2021, İstanbul, Turkey, 27 - 30 October 2021, pp.1-2, (Summary Text) Creative Commons License

12. Transient Elastography (fi broscan); As a New Non-invasiveDiagnostic Method for Detecting Hepatic Involvement ofAmyloidosis

Bektaş M., Çavuş B., Ağargün B. F., Şenkal İ. V., Koca N., İnce B., et al.
ACR, Arizona, United States Of America, 5 - 09 November 2021, vol.10, no.73, pp.1-4, (Summary Text) Creative Commons License

13. Transient Elastography (Fibroscan) as a Non-InvasiveMethod for Detecting Amyloid Deposition in TransplantedKidneys in Patients with AA Amyloidosis

Bektaş M., Çavuş B., Dirim A. B., Sarı S., Şenkal İ. V., Koca N., et al.
ACR, Arizona, United States Of America, 5 - 09 November 2021, vol.10, no.73, pp.1-5, (Summary Text) Creative Commons License

14. Karaciğer Transplantasyonunda Covid-19 Sıklığı Ve Risk Faktörleri

SEYİTHANOĞLU D., TELLİ P., BELOĞLU Y. N., YAKUT A., ŞENKAL İ. V., İMANOV Z., et al.
13. ULUSAL HEPATOLOJİ KONGRESİ, Turkey, 28 - 30 May 2021, (Summary Text)
Metrics

Publication

26

Publication (WoS)

10

Publication (Scopus)

9

Citation (WoS)

4

H-Index (WoS)

1

Citation (Scopus)

5

H-Index (Scopus)

1

Open Access

3
UN Sustainable Development Goals